Cart
sales@molnova.com
Home - Products - GPCR/G Protein - Cannabinoid Receptor - AM6545

AM6545

CAS No. 1245626-05-4

AM6545( —— )

Catalog No. M33829 CAS No. 1245626-05-4

AM6545 is a selective and potent peripheral restricted cannabinoid receptor 1 (CB1) antagonist that inhibits the CB2 receptor, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate-induced obese mice, and may be useful in the study of obesity and diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 135 Get Quote
5MG 204 Get Quote
10MG 302 Get Quote
25MG 664 Get Quote
50MG 907 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    AM6545
  • Note
    Research use only, not for human use.
  • Brief Description
    AM6545 is a selective and potent peripheral restricted cannabinoid receptor 1 (CB1) antagonist that inhibits the CB2 receptor, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate-induced obese mice, and may be useful in the study of obesity and diabetes.
  • Description
    AM6545 is a peripherally active, cannabinoid receptor antagonist with limited brain penetration. AM6545 binds to CB1 and CB2 receptors with Kis of 1.7 nM and 523 nM, respectively. AM6545 is a neutral antagonist. AM6545 can be used for the research of obesity and its complications.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1245626-05-4
  • Formula Weight
    556.46
  • Molecular Formula
    C26H23Cl2N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CCCC#CC=1C=CC(=CC1)C2=C(C(=NN2C3=CC=C(Cl)C=C3Cl)C(=O)NN4CCS(=O)(=O)CC4)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. N L Cluny, et al. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol. 2010 Oct;161(3):629-42.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Drinabant

    Drinabant is an orally active CB1 receptor antagonist. Drinabant inhibits the agonist-stimulated calcium signal with IC50 values of 25 nM and 10 nM for the hCB1-R and rCB1-R, respectively, and is ineffective for the hCB2-R.

  • PrNMI

    PrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist.

  • XL-001

    XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM.

Sign In Join Free